To date zinc carboxypeptidases have only been found in animals and actinomycete bacteria. A cDNA clone (MeCPA) for a novel fungal (Metarhizium anisopliae) carboxypeptidase (MeCPA) was obtained by using reverse transcription differential display polymerase chain reaction to identify pathogenicity genes. MeCPA resembles pancreatic carboxypeptidases in being synthesized as a precursor species (418 amino acids) containing a large amino-terminal fragment (99 amino acids). The mature (secreted) form of MeCPA shows closest amino acid identity to human carboxypeptidases A1 (35%) and A2 (37%). MeCPA was expressed in an insect cell line yielding an enzyme with dual A1 ؉ A2 specificity for branched aliphatic and aromatic COOH-terminal amino acids. However, in contrast to the very broad spectrum A ؉ B-type bacterial enzymes, MeCPA lacks B-type activity against charged amino acids. This is predictable as key catalytic residues determining the specificity of MeCPA are conserved with those of mammalian A-type carboxypeptidases. Thus, in evolutionary terms the fungal enzyme is an intermediate between the divergence of A and B forms and the differentiation of the A form into A1 and A2 isoforms. Ultrastructural immunocytochemistry of infected host (Manduca sexta) cuticle demonstrated that MeCPA participates with the concurrently produced endoproteases in procuring nutrients; an equivalent function to digestive pancreatic enzymes.The vertebrate pancreas synthesizes and secretes a subset of zinc carboxypeptidases that hydrolyze alimentary proteins and peptides from their COOH-terminal ends. These are traditionally classified into the A types (with a preference for apolar COOH-terminal residues) and the B types (with a preference for basic COOH-terminal residues) (1, 2). In contrast, actinomycetes (bacteria) produce carboxypeptidases with a dual A ϩ B specificity toward both neutral and basic substrates and the distinct vertebrate A and B types presumably arose from such a precursor (3, 4). Why or when in the course of evolution a single carboxypeptidase with both A and B specificities was abandoned in favor of multiple enzymes with more limited specificities is not known. The classification of carboxypeptidases into the A and B forms has been further expanded with the identification of the A1 and A2 isoforms in rat and humans. Carboxypeptidase A1 preferentially catalyzes aliphatic COOHterminal residues of peptide substrates, while the A2-type selectively acts on the bulkier aromatic COOH-terminal residues, being the only isoform that shows specificity toward tryptophan (2, 5, 6). Carboxypeptidase A2 is apparently absent from bovine pancreas, so in contrast the single carboxypeptidase gene has a relatively broad substrate specificity (2). A number of non-digestive zinc carboxypeptidases involved in hormone and neuropeptide processing, bioactive peptide activation or inactivation, or functional modulation of regulatory proteins have also been reported in the literature expanding the field of interest in metallocarboxypeptidases (1). ...